CL
IBDX icon

Choreo LLC’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Choreo LLC’s Portfolio IBDX Stock Details IBDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+7,974
New +$201K ﹤0.01% 1570

Other funds holding IBDX

ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SIC
Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

Choreo LLC's IBDX Position: Q2 2026 in Review

Choreo LLC opened a new position in iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q2 2026: 7,974 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1570 among its holdings.

228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Choreo LLC held 7,974 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $201K as of Q2 2026.
  • iShares iBonds Dec 2032 Term Corporate ETF was a new Choreo LLC position in Q2 2026.
  • iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1570 holding.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.